# OnCo record oropharyngeal-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/oropharyngeal-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "oropharyngeal-cancer" ;
  schema:name "Oropharyngeal cancer (tonsil and base of tongue)"@en ;
  schema:alternateName "Oropharynx cancer"@en, "Tonsil cancer"@en, "Base of tongue cancer"@en, "HPV-positive head and neck cancer"@en ;
  schema:description "Cancer of the tonsils and back of the tongue, a head and neck cancer, now comes mostly from HPV infection rather than smoking, and behaves like a different disease: it responds well to chemoradiation, most patients are cured, and the research question is how much treatment can safely be removed."@en ;
  schema:url <https://onco.cc/cancers/oropharyngeal-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Oropharyngeal_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Oropharyngeal_cancer> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/hpv-negative-head-and-neck-cancer/>, <https://onco.cc/cancers/laryngeal-cancer/>, <https://onco.cc/cancers/oral-cavity-cancer/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:trials <https://onco.cc/trials/de-escalate/>, <https://onco.cc/trials/orator/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-048-lancet-2019/>, <https://onco.cc/key-papers/paper-ang-hpv-oropharyngeal-nejm-2010/>, <https://onco.cc/key-papers/paper-rtog-1016-lancet-2019/>, <https://onco.cc/key-papers/paper-checkmate-141-ferris-nejm-2016/> ;
  onco:pipeline <https://onco.cc/trials/de-escalate/>, <https://onco.cc/technologies/adaptive-radiotherapy/>, <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:standardOfCare <https://onco.cc/technologies/hpv-testing/>, <https://onco.cc/technologies/tors/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/trials/rtog-1016/>, <https://onco.cc/trials/de-escalate/>, <https://onco.cc/trials/bonner-cetuximab-rt/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/trials/keynote-048/>, <https://onco.cc/trials/checkmate-141/>, <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/smoking-cessation-after-diagnosis/> .